News & Article

U-genes Biotechnology Co., Ltd. will participate in RNATx 2026: RNA Therapeutics — From Concept to Clinic, held from June 24–26, 2026. We look forward to connecting with partners across the RNA and oligonucleotide community and sharing how our nucleic acid chemistry products and custom synthesis solutions can support innovation from early research to therapeutic development.

U-genes Biotechnology Co., Ltd. will attend TIDES Europe 2025 at Booth #425, where we will present our nucleic acid chemistry portfolio, including GalNAc, solid supports, modified nucleotides, phosphoramidites, and chemical linkers.

U-genes Biotechnology Co., Ltd. was pleased to attend TIDES USA 2026 in Boston and connect with partners and customers across the oligonucleotide, biotechnology, pharmaceutical, and diagnostic industries.